Glioblasztóma: vizsgálatok itt: Franciaország

In Franciaország 37 Also abroad 424

37 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 2026. november 11.. Ask the study team whether a trial fits you.

1. fázisTaking people
Anti-GD2 ADC M3554 in Advanced Solid Tumors
Where
Bordeaux, Lille, Lyon, Nice
Életkor
18 év and over
People
65 worldwide
Run by
EMD Serono Research & Development Institute, Inc.
See details and how to joinNCT06641908 · EU 2024-513687-26-00
2/3. fázisTaking people
A Trial to Evaluate Multiple Regimens in Newly Diagnosed and Recurrent Glioblastoma
Where
Bron, Marseille, Paris
Életkor
18 év and over
People
2250 worldwide
Run by
Global Coalition for Adaptive Research
See details and how to joinNCT03970447 · EU 2024-511452-40-00
No phaseNot yet taking people in Franciaország
An Optimization Study Evaluating Safety and Efficacy of the Y-90 Glioblastoma (GBM) Device in Patients With Recurrent GBM
Where
Bron, Marseille
Életkor
18 év and over
People
30 worldwide
Run by
Boston Scientific Corporation
See details and how to joinNCT07867886
1. fázisNot yet taking people in Franciaország
Phase I/IIa study of concomitant radiotherapy with olaparib and temozolomide in unresectable high grade gliomas patients
Where
Amiens Cedex 2, Angers, Bordeaux Cedex, Caen Cedex 5, LE HAVRE, Le Havre Cedex, Lorient, Lyon, Paris, Rouen Cedex, Saint-Herblain Cedex, Toulouse
Életkor
18 év and over
People
91
Run by
Centre Francois Baclesse
See details and how to joinNCT03212742 · EU 2024-514144-85-02
1/2. fázisTaking people
A Study of Repotrectinib in Pediatric and Young Adult Subjects Harboring ALK, ROS1, OR NTRK1-3 Alterations
Where
Angers, Bordeaux, Lyon, Marseille, Villejuif
Életkor
Up to 25 év
People
75 worldwide
Run by
Turning Point Therapeutics, Inc.
See details and how to joinNCT04094610 · EU 2023-506464-14-00
No phaseNot yet taking people in Franciaország
Impact of Fluorescence-Guided Resection and Chemoradiotherapy on the Systemic Immune Response in Glioblastoma: A Kinetic Analysis of Immune Biomarkers.
Where
Lille
Életkor
18 év and over
People
17
Run by
University Hospital, Lille
See details and how to joinNCT07568782
No phaseNot yet taking people in Franciaország
Impact of Pesticide Exposure on Survival and Tumor Aggressiveness in Patients With Glioblastoma: A Prospective Clinical Study
Where
Toulouse
Életkor
18 év and over
People
120
Run by
Institut Claudius Regaud
See details and how to joinNCT07788430
No phaseTaking people
A Study to Better Understand the Biological and Molecular Mechanisms Involved in Glioblastoma Recurrence and Progression
Where
Bordeaux
Életkor
18 év and over
People
45
Run by
University Hospital, Bordeaux
See details and how to joinNCT07173829
1. fázisNot yet taking people in Franciaország
RIVKAL clinical trial for the first-in-human administration of BIM2b in participants with Glioblastoma
Where
Clamart
Életkor
18 év and over
People
36
Run by
Beta Innov
See details and how to join2023-508662-15-00 · EU 2023-508662-15-00
1/2. fázisTaking people
New Adjuvant Vaccine in Glioblastoma, a Phase 1/2a Study
Where
Besançon, Marseille, Paris, Paris Cedex 13, Rennes Cedex
Életkor
18 év to 75 év
People
35
Run by
Assistance Publique - Hôpitaux de Paris
See details and how to joinNCT06622434 · EU 2024-514567-26-00
3. fázisTaking people
Lomustine With and Without Reirradiation for First Progression of Glioblastoma: a Randomized Phase III Study
Where
Amiens Cedex 1, Bron, Clermont Ferrand Cedex1, Lille Cedex, Nice, Paris, Paris Cedex 13, St Herblain, Strasbourg
Életkor
18 év and over
People
411 worldwide
Run by
European Organisation for Research and Treatment of Cancer - EORTC
See details and how to joinNCT05904119 · EU 2023-505267-36-00
No phaseTaking people
Assessment of Early Post-operative Nuclear Imaging in Neurosurgery: a Safety and Feasibility Study in Patients Operated for Glioblastoma
Where
Créteil
Életkor
18 év and over
People
15
Run by
Beta Emitting Accurate Monitored Systems
See details and how to joinNCT07274397
No phaseNot yet taking people in Franciaország
Cerebral Connectivity and Metabolic Phenotype of Gliomas: Prospective Addition of DTI and Rs-fMRI to a Preoperative FDG PET Strategy, With Neuropsychological Correlates and Post-treatment Follow-up
Where
Strasbourg
Életkor
18 év and over
People
80
Run by
Centre Paul Strauss
See details and how to joinNCT07628257
No phaseNot yet taking people in Franciaország
Impact of Androgen Signaling on the Composition of the Immune Microenvironment in Glioblastomas
Where
Paris
Életkor
18 év to 55 év
People
40
Run by
Assistance Publique - Hôpitaux de Paris
See details and how to joinNCT07472387
No phaseTaking people
Study of Biologic Tumor and Plasma Biomarkers of Response to TTFields in Patients Treated for Newly Diagnosed Glioblastoma
Where
Toulouse
Életkor
18 év and over
People
80
Run by
Institut Claudius Regaud
See details and how to joinNCT06222138
2. fázisTaking people
Simultaneous Integrated Boost FDOPA Positron Emission Tomography (PET) Guided in Patients With Partially- or Non-operated Glioblastoma
Where
Nancy, Strasbourg, Vandœuvre-lès-Nancy
Életkor
18 év and over
People
75
Run by
Centre Paul Strauss
See details and how to joinNCT05653622
2. fázisTaking people
Contribution From PET-DOPA in Glioblastoma Re-irradiation - A Randomized Phase II Study
Where
Nancy, Strasbourg
Életkor
18 év and over
People
54
Run by
Centre Paul Strauss
See details and how to joinNCT05653635
2. fázisTaking people
Surgery for Recurrent Glioblastoma
Where
Dijon, Lyon, Marseille, Nice, Paris, Saint-Etienne, Strasbourg, Tours
Életkor
18 év and over
People
120 worldwide
Run by
Insel Gruppe AG, University Hospital Bern
See details and how to joinNCT02394626
No phaseTaking people
Prospective Cohort of Patients With Newly Diagnosed Glioblastoma: Analysis of MMP2 and MMP9 Expression and Correlation to Neuro-imaging Features.
Where
Marseille
Életkor
18 év and over
People
100
Run by
Assistance Publique Hopitaux De Marseille
See details and how to joinNCT03526822
No phaseTaking people
Study of Prognostic Biomarkers of Survival at 6 Months for Patients Treated With Bevacizumab Glioblastomas in First Relapse After Failure of Radiochemotherapy
Where
Amiens
Életkor
18 év and over
People
170
Run by
Centre Hospitalier Universitaire, Amiens
See details and how to joinNCT03144167
2. fázisNot yet taking people in Franciaország
Evaluation of UCPVax Vaccine +/- Pembrolizumab Combined With Standard Treatment as Adjuvant Therapy in Patients With Unmethylated MGMT Glioblastoma
Where
Besancon Cedex, Dijon, Marseille, Paris
Életkor
18 év and over
People
98
Run by
Centre Hospitalier Universitaire de Besancon
See details and how to joinNCT07347210 · EU 2024-514399-42-00
No phaseTaking people
Control Cohort CTRL COH
Where
Bron
Életkor
18 év and over
People
350
Run by
Hospices Civils de Lyon
See details and how to joinNCT05370079
2. fázisTaking people
Oxidative Phosphorylation Targeting In Malignant Glioma Using Metformin Plus Radiotherapy Temozolomide
Where
Bron, Marseille, Paris, Suresnes
Életkor
18 év and over
People
640 worldwide
Run by
Hopital Foch
See details and how to joinNCT04945148 · EU 2024-511026-31-01
No phaseNot yet taking people in Franciaország
Correlative Analysis Between Magnetic Resonance Spectroscopy (MRS) and Essential Clinicobiological Data in Glioblatoma Multiforme (GBM)
Where
Amiens
Életkor
18 év and over
People
30
Run by
Centre Hospitalier Universitaire, Amiens
See details and how to joinNCT07211841
No phaseTaking people
Deciphering Mechanisms Underlying Cancer Immunogenicity
Where
Toulouse
Életkor
18 év and over
People
1100
Run by
Institut Claudius Regaud
See details and how to joinNCT03958240